No-Needle weight loss patch enters human testing
NCT ID NCT07673900
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This early-stage study tests a new way to deliver semaglutide—a drug used for weight management—using a small, needle-free patch that sticks to the skin. The patch, called VX-201, aims to provide the same benefits as injections without the need for needles. The trial includes healthy adults who are overweight or obese and compares the patch to standard semaglutide injections to see if it is safe and how well the drug enters the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
semaglutide (delivered via microneedle patch)
What this could lead to
If successful, this could offer a needle-free alternative to daily or weekly injections for weight management, making treatment easier and more comfortable.
What could go wrong
This is an early Phase 1 study focused on safety and dosing, so it is too soon to know if the patch works as well as injections. Skin reactions or inconsistent drug absorption are possible risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND/OR OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion Clinical Research
RECRUITINGTempe, Arizona, 85283, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••